Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
WCLC 2019Unprecedented Survival in Lung Cancer With ImmunotherapyImmunotherapy with PD-1/PDL-1 checkpoint inhibitors is transforming the landscape in advanced non-small cell lung cancer, prolonging survival to unprecedented lengths compared with chemotherapy alone.
Durvalumab New Standard in Stage III Unresectable Lung CancerNow with data showing an overall survival advantage, the immunotherpy sets new standard of care in stage III unresectable
lung cancer following concurrent chemotherapy and radiotherapy.
